Clinical trial

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

NCT03386851

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-12-13

PhaseN/A

Study timeline

Study start (actual)2016-12-13Date precision: day

Registry last updated2022-02-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Bipolar 1 Disorderunresolved

Interventions

Sponsors & collaborators

Korea Otsuka Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03386851 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.